Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia

Acta Neurologica Scandinavica

Volumn 103, Issue 3, 2001, Pages 166-174

  Tarkowski, E ^a,b   Wallin, A ^a,b   Regland, B ^a,b   Blennow, K ^a,b   Tarkowski, A ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b VARBERG HOSPITAL   (Sweden)

Author keywords

bcl 2; Cerebrospinal fluid; Cytokines; Dementia; Fas APO 1; Granulocyte macrophage colony stimulating factor; Tau protein

Indexed keywords

CYTOKINE; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN BCL 2; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN INJURY; CELL GROWTH; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HUMAN; INFLAMMATION; MALE; MICROGLIA; MULTIINFARCT DEMENTIA; PATHOPHYSIOLOGY; PHENOTYPE; QUANTITATIVE ASSAY;

AGED; ALZHEIMER DISEASE; APOPTOSIS; BRAIN; DEMENTIA, VASCULAR; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MICROGLIA; MIDDLE AGED; NEURONS;

EID: 0035132281     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2001.103003166.x     Document Type: Article

References (55)

1. Prevalence and neurobiology of Alzheimer disease: Some highlights
2. Disorders of psychic function. Dementia
3. Alzheimer's disease
4. Relationship of microglia and astrocytes to amyloid deposit in Alzheimer's disease
5. Microglia in cerebellar plaques in Alzheimer's disease
6. Reactive microglia in patients with senile dementia of Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR
7. Microglia: Intrinsic immuneffector cell of the brain
8. Synaptic stripping in the human facial nucleus
9. Ultrastructure of the cells forming amyloid fibers in Alzheimer's disease and scrapie
10. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
11. Immune system response in Alzheimer's disease
12. Effects of Cytokines on the CNS cells: Glia
13. The participation of interleukin-6 in the pathogenesis of Alzheimer's disease
14. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease
15. The pathogenetic basis of vascular dementia
16. Subcortical arteriosclerotic encephalopathy: CT spectrum and pathologic correlation
17. Deep white matter damage and hypertension: "Binswanger's disease"
18. Decreased myelin lipids in Alzheimer's disease and vascular dementia
19. Intrathecal synthesis of immunoglobulin G in vascular dementia
20. Perivascular deposits of serum proteins in cerebral cortex in vascular dementia
21. A new rating scale for dementia syndromes
22. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-ARIEN International workshop
23. Decreased lumbar CSF levels of monoamine metabolites in vascular dementia
24. Research criteria for clinical diagnosis of "pure" Alzheimer's disease
25. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Detection of gamma interferon-secreting cells
26. Increased systemic T-lymphocyte reactivity in patients with established stroke
27. Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer's disease?
28. A sharper Bonferroni procedure for multiple tests of significance
29. Presence of parietotemporal symptomatology distinguishes early- and late-onset Alzheimer disease
30. Production of granulocyte/macrophage colony-stimulating factor by cultured astrocytes
31. Production of hemolymphopoietic cytokines (IL-6, IL-8, Colony Stimulating factors) by normal human astrocytes in response to IL-1b and tumor necrosis factor-α
32. Production of hemopoietic colony-stimulating factors by astrocytes
33. Granulocyte-macrocyte colony stimulating factor
34. The impact of microglial-derived cytokines upon gliosis in the CNS
35. Colony-stimulating factors regulate programmed cell death of rat microglia/brain macrophages in vitro
36. GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures
37. Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease
38. Apoptosis is induced by β-amyloid in cultured central nervous neurons
39. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines
40. Microglia and neuronal dysfunction
41. A novel protein domain required for apoptosis
42. Localization of Fas antigen m-RNA induced in postischemic murine forebrain by the in situ hybridization
43. Increased immunoreactivity of jun- and fos-related proteins in Alzheimer's disease: Association with pathology
44. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-jun immunoreactivity, relationship to brain area, and effect of postmortem delay
45. Development of tissue damage, inflammation and resolution following stroke: An immunohistochemical and quantitative planimetric study
46. Intrathecal release of pro- and anti-inflammatory cytokines during stroke
47. Identification and characterization of a high-affinity granulocyte-macrophage colony stimulating factor receptor on primary rat oligodendrocytes
48. Phagocytosis of myelin by microglia in vitro
49. Diagnostic accuracy of Alzheimer's disease: A clinicopathological study
50. Diagnostic accuracy of Alzheimer's disease: A neuropathological study
51. Correlation of cytokine secretion by mononuclear cells of Alzheimer's patients and their disease stage
52. Neuroimmunology of aging and Alzheimer's disease with emphasis on cytokines
53. The syntax of immune-neuroendocrine communication
54. Altered T-lymphocyte responses in patients with stroke. Effect of sympathetic dysfunction?
55. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke